Persistence of vaccine immunity against canine parvovirus and canine distemper virus for determination of vaccine protocol in dogs: impacts and challenges in Brazil
DOI:
https://doi.org/10.33448/rsd-v10i11.19472Keywords:
Antigen; CDV; CPV-2; Vaccines.Abstract
Vaccine protocols were established for dogs and cats, considering the circulating period of maternal antibodies from the puppies, the type of antigen used to make the vaccines and the vaccine immunity duration. This study aimed to approach the duration of vaccine immunity against the canine parvovirus (CPV-2) and the canine distemper virus (CDV), as determining factor to choose the adequate vaccine protocol, besides to stand out the main implications found in Brazil that difficult the application of these current protocols, as the technical challenges to use them. For that, this article described some information about the types of current vaccines, the immunity duration against the CPV-2 and CDV, as well the respective vaccine protocols that were applied. The searches were done in the database of PubMed, SciELO, Google Scholar, Capes Journals and academic books, by the following keywords: vaccination guidelines; humoral immune response; vaccination strategy; distemper; parvovirus infection; and duration of vaccine immunity. Considering the facts, it is understood that the annual revaccination against the CPV-2 and CDV for dogs must be individually assessed, because the vaccine immunity has an average duration of three years, that is, the best alternative for the animal would be the application of routine serological tests, aiming to assess if the antibodies titration remains protective. Another alternative is the use of divalent or trivalent vaccines.
References
Abdelmagid, O. Y., Larson, L., Payne, L., Tubbs, A., Wasmoen, T., & Schultz, R. (2004). Evaluation of the efficacy and duration of immunity of a canine combination vaccine against virulent parvovirus, infectious canine hepatitis virus, and distemper virus experimental challenges. Veterinary Therapeutics: Research In Applied Veterinary Medicine, 5, 173-186.
Alves, C. D. B. T., Granados, O. F. O., Budaszewski, R. F., Streck, A. F., Weber, M. N., Cibulski, S. P., Pin, L. D., Ikuta, N., & Canal, C. W. (2018). Identification of enteric viruses circulating in a dog population with low vaccine coverage. Brazilian Journal of Microbiology, 49, 790-794.
Banerji, N., Kapur, V., & Kanjilal, S. (2007). Association of Germ-line Polymorphisms in the Feline p53 Gene with Genetic Predisposition to Vaccine-Associated Feline Sarcoma. Journal of Heredity, 98, 421-427.
Bohm, M., Thompson, H., Weir, A., Hasted, A. M., Maxwell, N. S., & Herrtage, M. E. (2004). Serum antibody titres to canine parvovirus, adenovirus and distemper vírus in dogs in the UK which had not been vaccinated for at least three years. The Veterinary Record, 154, 457-463.
Costa, V. G., Saivish, M. V., Rodrigues, R. L., Silva, R. F. L., Moreli, M. L., & Krüger, R. H. (2019). Molecular and serological surveys of canine distemper virus: a meta-analysis of cross-sectional studies. PlosOne, 14, e0217594.
Day, M. J., Horzinek, M. C., Schultz, R. D., & Squires, R. A. (2016). Guidelines for the vaccination of dogs and cats. Journal of Small Animal Practice, 57, E1-E45.
Day, M. J., Crawford, C., Marcondes, M., & Squires R. A. (2020). Recomendações sobre a vacinação para médicos veterinários de pequenos animais da América Latina: um relatório do Grupo de Diretrizes de Vacinação da WSAVA. Journal of Small Animal Practice, 1-39.
Dezengrini, R., Weiblen, R., & Flores, E. F. (2007). Seroprevalence of parvovirus, adenovirus, coronavirus and canine distemper virus infections in dogs of Santa Maria, Rio Grande do Sul, Brazil. Ciência Rural, 37, 183-189.
Ford, R. B. (2004). Recomendações para Vacinação de Cães e Gatos. In: Birchard, S. J., & Sherding, R. G. Manual saunders clínica de pequenos animais. São Paulo: Roca, 109-116.
Gore, T. C., Lakshmanan, N., Duncan, K. L., Coyne, M. J., Lum, M. A., & Sterner, F. J. (2005). Three-year duration of immunity in dogs following vaccination against canine adenovirus type-1, canine parvovirus, and canine distemper virus. Veterinary Therapeutics: Research In Applied Veterinary Medicine, 6, 5-14.
Greene, C. E., Schultz, R. D., & Ford, R. B. (2001). Canine Vaccination. Veterinary Clinics: Small Animal Practice, 31, 473-492.
Headley, S. A., Oliveira, T. E. S., Pereira, A. H. T., Moreira, J. R., Michelazzo, M. M. Z., Pires, B. G., Marutani, V. H. B., Xavier, A. A. C., Di Santis, G. W., Garcia, J. L., & Alfieri, A. A. (2018). Canine morbillivirus (canine distemper virus) with concomitant canine adenovirus, canine parvovirus-2, and Neospora caninum in puppies: a retrospective immunohistochemical study. Scientific Reports, 8, 13477.
Labarthe, N., Merlo, A., Mendes-de-Almeida, F., Costa, R., Dias, J., Autran-de-Morais, H., & Guerrero, J. (2016). Colavac/Fiavac - Estratégias para vacinação de animais de companhia: cães e gatos. Clínica Veterinária, 124, 114-120.
Lappin, M. R. (2010). Prevenção de Doenças Infecciosas. In: Nelson, R. W., & Couto, C. G. Medicina Interna de Pequenos Animais. Rio de Janeiro: Elsevier, 1304-1305.
Larson, L. J., & Schultz, R. D. (2007). Three-year serologic immunity against canine parvovirus type 2 and canine adenovirus type 2 in dogs vaccinated with a canine combination vaccine. Veterinary Therapeutics: Research In Applied Veterinary Medicine, 8, 305-310.
Mitchell, S. A., Zwijnenberg, R. J., Huang, J., Hodge, A., & Day, M. J. (2012). Duration of serological response to canine parvovirus-type 2, canine distemper virus, canineadenovirus type 1 and canine parainfluenza virus in client-owned dogs in Australia. Australian Veterinary Journal, 90, 468-473.
Moore, G. E., & Hogenesch, H. (2010). Adverse Vaccinal Events in Dogs and Cats. Veterinary Clinics: Small Animal Practice, 40, 393-407.
Munday, J. S., Stedman, N. L., & Richey, L. J. (2003). Histology and immunohistochemistry of seven ferret vaccination-site fibrosarcomas. Veterinary Pathology, 40, 288-293.
Paul, M. A., Appel, M., Barret, R., Carmichael, L. E., Childers, H., Cotter, S., Davidson, A., Ford, R., Keil, D., Lappin, M., Schultz, R. D., Thacker, E., Trumpeter, J. L., Welborn, L., & American Animal Hospital Association Canine Vaccine Task Force. Report of the American Animal Hospital Association (AAHA) Canine Vaccine Task Force: executive summary and 2003 canine vaccine guidelines and recommendations. Journal of the American Animal Hospital Association, 39, 119-131.
Pereira, A. S., Shitsuka, D.M., Parreira, F. J. & Shitsuka, R. (2018). Metodologia da Pesquisa Científica. Santa Maria: Universidade Federal de Santa Maria.
Rashid, A., Rasheed, K., Asim, M., & Hussain, A. (2009). Risks of Vaccination: a Review. Journal of Venomous Animals and Toxins including Tropical Diseases, 15, 19-27.
Roth, J. A., & Spickler, A. R. (2010). Duration of immunity induced by companion animal vaccines. Animal Health Research Reviews, 11, 165-190.
Scavone, R. (2014). O Uso de Vacinas. In: Tizard, I. R. Imunologia veterinária. Elsevier, 585-606.
Strasser, A., May, B., Teltscher, A., Wistrela, E., & Niedermüller, H. (2003). Immune modulation following immunization with polyvalent vaccines in dogs. Veterinary Immunology and Immunopathology, 94, 113-121.
Twark, L., & Dodds, W. J. (2000). Clinical use of sérum parvovirus and distemper vírus antibody titers for determining revaccination strategies in healthy dogs. Journal of the American Veterinary Medical Association, 217, 1021-1024.
Vila-Nova, B., Cunha, E., Sepúlveda, N., Oliveira, M., Braz, B. S., Tavares, L., Almeida, V., & Gil, G. (2018). Evaluation of the humoral immune response induced by vaccination for canine distemper and parvovirus: a pilot study. BMC Veterinary Research, 14, 348.
Vilela, M. (2016). Os novos desafios do protocolo de vacinação. Revista Vet Science Magazine, 23, 20-35.
Wolf, A. M. (2010). Canine and feline vaccination: protocols, products, and problems. In: 110th Penn Annual Conference. 16-23.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Raiany Borges Duarte; Samara Moreira Felizarda; Mayra Parreira Oliveira; Júlia Martins Soares; Ísis Indaiara Gonçalves Granjeiro Taques; Raphaella Barbosa Meirelles-Bartoli; Dirceu Guilherme de Souza Ramos; Ísis Assis Braga
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
